Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NeoAg-mBRAF |
| Trade Name | |
| Synonyms | NeoAg mBRAF|BRAF 585-614 (V600E)|BRAF585-614-V600E|BRAF 585-614 V600E |
| Drug Descriptions |
NeoAg-mBRAF is a peptide consisting of aa 585-614 of the Braf protein with the BRAF V600E mutation, which may lead to cytotoxic T-lymphocyte mediated immune response against BRAF V600E-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C177247 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| 6MHP vaccine + CDX-1140 + NeoAg-mBRAF + Poly ICLC | 6MHP vaccine CDX-1140 NeoAg-mBRAF Poly ICLC | 0 | 1 |
| 6MHP vaccine + NeoAg-mBRAF + Poly ICLC | 6MHP vaccine NeoAg-mBRAF Poly ICLC | 0 | 0 |
| NeoAg-mBRAF | NeoAg-mBRAF | 0 | 0 |